CryoPort, Inc. CYRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Life Sciences Products | $20.86M+16.0% | $18.98M0.0% | $18.82M+10.3% | $19.99M— | $17.98M— | |
| Life Sciences Services | $27.91M+19.0% | $26.94M+18.4% | $25.73M+19.6% | $26.02M— | $23.46M— | |
| Segment Reporting Other Item Amount by Business | ||||||
| Life Sciences Products | $1.48M+34.2% | $1.48M+21.2% | $1.42M+35.7% | $1.48M— | $1.1M— | |
| Life Sciences Services | $4.04M+17.4% | $2.84M-9.5% | $1.13M-63.4% | $2.95M— | $3.45M— | |
| Adjusted Earnings Before Interest Tax Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $3.67M+4.5% | $3.28M-22.3% | $3.5M+23.9% | $4.01M— | $3.51M— | |
| Life Sciences Services | -$96K+96.1% | -$282K+85.7% | $1.6M+203% | -$54K— | -$2.48M— | |
| Research And Development Expense Excluding Compensation And Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $513K+24.5% | $614K+6.6% | $766K+49.9% | $557K— | $412K— | |
| Life Sciences Services | $202K-79.5% | $817K-11.7% | $793K-30.7% | $930K— | $983K— | |
| Cost Of Goods And Services Sold Excluding Rent Compensation And Depreciation And Amortization by Business | ||||||
| Life Sciences Products | $9.07M+23.7% | $7.83M+1.2% | $7.23M+4.7% | $8.13M— | $7.33M— | |
| Life Sciences Services | $7.05M+5.9% | $7.43M+20.0% | $7.01M+18.1% | $7.18M— | $6.66M— | |
| Rent Expenses by Business | ||||||
| Life Sciences Products | $178K-4.8% | $200K+7.5% | $192K-3.5% | $186K— | $187K— | |
| Life Sciences Services | $1.85M+2.7% | $1.97M+32.1% | $1.98M+77.2% | $1.89M— | $1.8M— | |
| Labor And Related Expense by Business | ||||||
| Life Sciences Products | $5.95M+9.5% | $5.57M+10.7% | $5.71M+2.3% | $5.63M— | $5.44M— | |
| Life Sciences Services | $14.86M+13.9% | $14.16M+9.1% | $13.21M+12.3% | $13.13M— | $13.05M— | |
| Cost Of Revenue by Product | ||||||
| Product | $12.14M+15.8% | $10.88M-0.8% | $10.71M+6.4% | $11.63M+2.9% | $10.48M-6.6% | |
| Service | $13.75M+15.3% | $12.86M+17.0% | $12.2M+12.7% | $12.45M+15.9% | $11.92M+8.3% | |
| Revenue by Product | ||||||
| Biologistics Solutions | $21.67M+16.9% | $20.31M+16.2% | $19.43M+14.6% | $19.87M+19.5% | $18.53M+16.1% | |
| Biostorage Bioservices | $5.23M+20.7% | $4.7M+17.6% | $4.83M+21.5% | $4.5M+27.6% | $4.33M+22.8% | |
| Revenue by Geography | ||||||
| Americas | $34.96M+8.6% | $32.69M+10.4% | $33.14M+19.1% | $33.24M+13.0% | $32.2M+20.6% | |
| Asia Pacific | $3.89M+19.1% | $5.68M+14.2% | $4.46M+4.2% | $6.38M+70.0% | $3.27M+2.0% | |
| EMEA | $8.95M+60.4% | $7.09M+2.9% | $6.63M+6.9% | $5.83M-10.7% | $5.58M-24.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CryoPort, Inc. break its business down?
- CryoPort, Inc. (CYRX) reports revenue by business across 2 parts — Life Sciences Products and Life Sciences Services. Each is extracted from the segment footnotes and tracked over time.
- Where does CryoPort, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CryoPort, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
